The sodium correction factor for dogs undergoing treatment for a hyperglycemic crisis is a 1.6-mEq/L decrease in
Journal of the American Veterinary Medical Association
|February 28, 2024
Summary
A sodium correction factor of 1.6 mEq/L is recommended for hyperglycemic diabetic dogs. This value helps adjust sodium levels for accurate clinical assessment in diabetic canine patients.
Area of Science:
- Veterinary Medicine
- Endocrinology
- Internal Medicine
Background:
- Hyperglycemia in diabetic dogs can lead to inaccurate serum sodium measurements.
- Accurate sodium assessment is crucial for managing diabetic ketoacidosis and other hyperglycemic states.
Purpose of the Study:
- To establish a reliable sodium correction factor for clinical use in hyperglycemic dogs.
- To provide veterinarians with a tool for more precise electrolyte management in diabetic canines.
Main Methods:
- Retrospective analysis of 76 hospitalization episodes in dogs with hyperglycemia.
- Paired sodium and glucose measurements were analyzed using linear mixed models.
- Correction factor determined per 100-mg/dL increase in blood glucose.
Main Results:
- A sodium correction factor of 1.6 mEq/L decrease per 100-mg/dL glucose increase was calculated.
- Confidence interval for the factor was 1.3 to 1.9 mEq/L.
- Most dogs received standard treatments like crystalloids, insulin, and electrolyte supplementation.
Conclusions:
- A sodium correction factor of 1.6 mEq/L is recommended for clinical application in hyperglycemic diabetic dogs.
- This factor aids in correcting serum sodium for accurate interpretation in diabetic patients.
Related Concept Videos
01:15Hypoglycemia and Glucagon
260
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
260
01:16Insulin: Dosing Regimen and Adverse Effects
170
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
170
01:15Diabetes: Management and Pharmacotherapy
282
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
282
01:15Diabetes: Symptoms, Diagnosis, and Complications
534
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
534
01:22Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
01:11Renal Failure: Dose Adjustments
88
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88